Early Osteoarthritis Clinical Trial
Official title:
Clinical and Molecular Aspects of Early Osteoarthritis
Verified date | February 2020 |
Source | University Hospital, Montpellier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The etiology of osteoarthritis is varied, ranging from multifactorial, environmental to
monogenic. In individuals in whom osteoarthritis appears earlier than in the general
population, it is called early osteoarthritis. To our knowledge, there are no large-scale
genetic studies on people with early osteoarthritis. The investigators therefore sought to
study the causes of monogenic osteoarthritis in people suffering from early non-syndromic
osteoarthritis.
Material and method From 2013 to 2019, experts in constitutional bone disease sent patients
with non-syndromic early osteoarthritis for genetic analysis to our center of competence for
constitutional bone diseases. The sequencing of a panel of genes was carried out by NGS.
Status | Completed |
Enrollment | 65 |
Est. completion date | January 1, 2020 |
Est. primary completion date | December 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 7 Years and older |
Eligibility |
Inclusion Criteria: - Patients with early osteoarthritis who have undergone genetic sequencing Exclusion Criteria: - Patients refusing to participate in research |
Country | Name | City | State |
---|---|---|---|
France | UH Montpellier | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | identification of genetic mutation | sequencing out by NGS | 1 day | |
Primary | number of genetic mutation | sequencing out by NGS | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01747018 -
Platelet Rich Plasma Injection for Knee Pain
|
Phase 1/Phase 2 |